Copper inhibits activated protein C: Protective effect of human albumin and an analogue of its high-affinity copper-binding site, d-DAHK

被引:9
作者
Bar-Or, D
Rael, LT
Winkler, JV
Yukl, RL
Thomas, GW
Shimonkevitz, RP
机构
[1] Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80110 USA
[2] DMI Biosci Inc, Englewood, CO 80110 USA
关键词
activated protein C; copper; human albumin; sepsis; anticoagulation; inflammation; acidosis; ischemia; Asp-Ala-His-Lys; DAHK;
D O I
10.1006/bbrc.2002.6363
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activated protein C (APC) is useful in the treatment of sepsis. Ischemia and acidosis, which often accompany sepsis, cause the release of copper from loosely bound sites. We investigated (i) whether physiological concentrations of copper inhibit APC anticoagulant activity and (ii) if any copper-induced A-PC inhibition is reversible by human serum albumin (HSA) or a high-affinity copper-binding analogue of the human albumin N-terminus, d-Asp-d-Ala-d-His-d-Lys (dDAHK). APC activity after 30 min of incubation with Cucl(2) (10 muM) was decreased 26% below baseline. HSA, both alone and when combined with various ratios of CuCl2 increased APC activity significantly above baseline. d-DAHK alone and 2:1 and 4:1 ratios of dDAHK:CuCl2 also increased APC activity. A-PC contained 1.4 muM copper, which helps explain the increased APC activity with HSA and d-DAHK alone. These in vitro results indicate that copper inhibits A-PC activity and that albumin and d-DAHK reverse the copper-induced APC deactivation. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:1388 / 1392
页数:5
相关论文
共 47 条
[1]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[2]   An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species [J].
Bar-Or, D ;
Rael, LT ;
Lau, EP ;
Rao, NKR ;
Thomas, GW ;
Winkler, JV ;
Yukl, RL ;
Kingston, RG ;
Curtis, CG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (03) :856-862
[3]   Asp-Ala-His-Lys (DAHK) inhibits copper-induced oxidative DNA double strand breaks and telomere shortening [J].
Bar-Or, D ;
Thomas, GW ;
Rael, LT ;
Lau, EP ;
Winkler, JV .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (01) :356-360
[4]   Characterization of the Co2+ and Ni2+ binding amino-acid residues of the N-terminus of human albumin -: An insight into the mechanism of a new assay for myocardial ischemia [J].
Bar-Or, D ;
Curtis, G ;
Rao, N ;
Bampos, N ;
Lau, E .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (01) :42-47
[5]   Patterns of mobilization of copper and iron following myocardial ischemia: Possible predictive criteria for tissue injury [J].
Berenshtein, E ;
Mayer, B ;
Goldberg, C ;
Kitrossky, N ;
Chevion, M .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (11) :3025-3034
[6]   Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis [J].
Bernard, GR ;
Ely, EW ;
Wright, TJ ;
Fraiz, J ;
Stasek, JE ;
Russell, JA ;
Mayers, I ;
Rosenfeld, BA ;
Morris, PE ;
Yan, SB ;
Helterbrand, JD .
CRITICAL CARE MEDICINE, 2001, 29 (11) :2051-2059
[7]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[8]   LACTATED RINGER SOLUTION VERSUS 3-PERCENT ALBUMIN FOR RESUSCITATION OF A LETHAL INTESTINAL ISCHEMIC SHOCK IN RATS [J].
DAWIDSON, IJA ;
WILLMS, C ;
SANDOR, ZF ;
ARMSTRONG, J ;
WILSON, L .
CRITICAL CARE MEDICINE, 1990, 18 (01) :60-66
[9]   THE PROTEIN-C ANTICOAGULANT PATHWAY [J].
ESMON, CT .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (02) :135-145
[10]   Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation [J].
Esmon, CT .
CRITICAL CARE MEDICINE, 2001, 29 (07) :S48-S51